Clinical Trials Directory

Trials / Completed

CompletedNCT04632719

The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19

MentalPlus® for Assessment and Rehabilitation of Cognitive Functions After Remission of Symptoms of COVID-19

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
8 Years – 88 Years
Healthy volunteers
Accepted

Summary

This study evaluates and rehabilitates the cognitive functions of attention, memory, visual perception, language, and executive by the mentalPlus® digital game of COVID-19 surviving patients after remission of symptoms.

Detailed description

Subjects who contracted COVID-19 and present remission of symptoms will be studied, with different age groups, illiterate or literate, of both genders and with different socio-demographic characteristics. The volunteers will be submitted to the application of MentalPlus® to assess cognitive functions and SF-8® to assess Quality of Life.

Conditions

Interventions

TypeNameDescription
DEVICEThe use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19Cognitive assessment and rehabilitation will be carried out on volunteers who have healed from COVID-19.

Timeline

Start date
2020-11-08
Primary completion
2020-12-29
Completion
2023-12-29
First posted
2020-11-17
Last updated
2024-03-07

Locations

2 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04632719. Inclusion in this directory is not an endorsement.